Montgomery, TX, United States of America

Jennifer Ann Dzielawa

This inventor holds 1 USPTO granted patent. Top assignee: Fortis Life Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Ann Dzielawa. Retrieved from https://idiyas.com/inventor/jennifer-ann-dzielawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jennifer Ann Dzielawa

Introduction

Jennifer Ann Dzielawa is an accomplished inventor based in Montgomery, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work is characterized by a commitment to advancing medical science and improving health outcomes.

Latest Patents

Jennifer holds a patent for "Anti-Ceruloplasmin Antibodies and Uses Thereof." This innovative patent reflects her expertise and dedication to addressing critical health issues through scientific research. The patent is a testament to her ability to create impactful solutions in the medical field. She has 1 patent to her name.

Career Highlights

Jennifer is currently employed at Fortis Life Sciences, where she continues to push the boundaries of scientific research. Her role at the company allows her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Brenda Sue Carter and Mark Ma. Their collective efforts contribute to the innovative environment at Fortis Life Sciences.

Conclusion

Jennifer Ann Dzielawa exemplifies the spirit of innovation in biotechnology. Her patent and work at Fortis Life Sciences highlight her contributions to the field. She continues to inspire others with her dedication to improving health through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…